These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38381517)

  • 1. Gut Microbiota and Nutrition: Strategies for the Prevention and Treatment of Type 2 Diabetes.
    Sastre M; Cimbalo A; Mañes J; Manyes L
    J Med Food; 2024 Feb; 27(2):97-109. PubMed ID: 38381517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and Prebiotics as Dietary Supplements for the Adjunctive Treatment of Type 2 Diabetes.
    Wang Y; Wen L; Tang H; Qu J; Rao B
    Pol J Microbiol; 2023 Mar; 72(1):3-9. PubMed ID: 36929892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiome Changes in Gestational Diabetes.
    Ionescu RF; Enache RM; Cretoiu SM; Gaspar BS
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
    Huda MN; Kim M; Bennett BJ
    Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes.
    Sharma BR; Jaiswal S; Ravindra PV
    Biomed Pharmacother; 2022 Aug; 152():113148. PubMed ID: 35665671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
    Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considering gut microbiota in treatment of type 2 diabetes mellitus.
    Adeshirlarijaney A; Gewirtz AT
    Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
    Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
    Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota dysbiosis -associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review.
    Hamjane N; Mechita MB; Nourouti NG; Barakat A
    Microvasc Res; 2024 Jan; 151():104601. PubMed ID: 37690507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Evidence on the Use of Probiotics and Prebiotics to Improve the Gut Microbiota of Older Adults with Frailty Syndrome: A Narrative Review.
    Sánchez Y Sánchez de la Barquera B; Martínez Carrillo BE; Aguirre Garrido JF; Martínez Méndez R; Benítez Arciniega AD; Valdés Ramos R; Soto Piña AE
    J Nutr Health Aging; 2022; 26(10):926-935. PubMed ID: 36259581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics, prebiotics, synbiotics and insulin sensitivity.
    Kim YA; Keogh JB; Clifton PM
    Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice.
    Bagarolli RA; Tobar N; Oliveira AG; Araújo TG; Carvalho BM; Rocha GZ; Vecina JF; Calisto K; Guadagnini D; Prada PO; Santos A; Saad STO; Saad MJA
    J Nutr Biochem; 2017 Dec; 50():16-25. PubMed ID: 28968517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review.
    Sadagopan A; Mahmoud A; Begg M; Tarhuni M; Fotso M; Gonzalez NA; Sanivarapu RR; Osman U; Latha Kumar A; Mohammed L
    Cureus; 2023 Jul; 15(7):e41559. PubMed ID: 37554593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prebiotics as a Tool for the Prevention and Treatment of Obesity and Diabetes: Classification and Ability to Modulate the Gut Microbiota.
    Megur A; Daliri EB; Baltriukienė D; Burokas A
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.
    Ghorbani Y; Schwenger KJP; Allard JP
    Eur J Nutr; 2021 Aug; 60(5):2361-2379. PubMed ID: 33651137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
    Wu J; Yang K; Fan H; Wei M; Xiong Q
    Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.